NCAM1 Recombinant Monoclonal Antibody

Code: CSB-RA015511MA1HU

Rate （N/A）
Review （0）

Size:

50μl100μl

US$210

Quantity:

Species Reactivity: Human

Application: ELISA, FC

Send an Inquiry

Start an on-line Chat

Online ordering is currently available for U.S. customers only. For orders outside the U.S., please kindly submit an inquiry or start a chat with us.

Product Details
Related Products
Customer Reviews and Q&A
Target Background

Product Details

Uniprot NO.

P13591

Target Names

NCAM1

Alternative Names

antigen MSK39 identified by monoclonal antibody 5.1H11 antibody; antigen recognized by monoclonal antibody 5.1H11 antibody; CD56 antibody; cell adhesion molecule, neural, 1 antibody; MSK 39 antibody; MSK39 antibody; N-CAM-1 antibody; NCAM 1 antibody; NCAM antibody; NCAM C antibody; NCAM-1 antibody; NCAM1 antibody; NCAM1_HUMAN antibody; NCAMC antibody; Neural cell adhesion molecule 1 antibody; Neural cell adhesion molecule NCAM antibody; OTTHUMP00000235666 antibody

Species Reactivity

Human

Immunogen

Recombinant Human NCAM1 protein

Conjugate

Non-conjugated

Clonality

Monoclonal

Isotype

hIgG1

Clone No.

14C10

Purification Method

Affinity-chromatography

Concentration

It differs from different batches. Please contact us to confirm it.

Buffer

Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M PBS, PH 7.4

Form

Liquid
Note: We will preferentially ship the format that we have in stock, however, if you have any special requirement for the format, please remark your requirement when placing the order, we will prepare according to your demand.

Scope Application

ELISA Protocol Flow Cytometry (FC) Protocol

Recommended Dilution

Application	Recommended Dilution
ELISA	1:5000-1:50000
FC	1:50-1:500

Storage

Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.

Lead Time

Basically, we can dispatch the products out in 1-3 working days after receiving your orders. Delivery time maybe differs from different purchasing way or location, please kindly consult your local distributors for specific delivery time.
Note: All of our proteins are default shipped with normal blue ice packs, if you request to ship with dry ice, please communicate with us in advance and extra fees will be charged.

Usage

For Research Use Only. Not for use in diagnostic or therapeutic procedures.

Datasheet & COA

Antibody FAQs

Images

The Binding Activity of Human NCAM1 with Anti-NCAM1 recombinant antibody
Activity: Measured by its binding ability in a functional ELISA.Immobilized Human NCAM1（CSB-MP015511HU1（F2）） at 2 μg/mL can bind Anti-NCAM1 recombinant antibody.The EC₅₀ is 0.8869-1.024 ng/mL.
Overlay Peak curve showing SH-SY5Y cells stained with CSB-RA015511MA1HU (red line) at 1:100. Then 10% normal goat serum to block non-specific protein-protein interactions followed by the antibody (1ug/1*10⁶cells) for 45min at 4℃. The secondary antibody used was Fluorescein (FITC) AffiniPure Goat Anti-Human IgG, Fcγ fragment specific at 1:200 dilution for 35 min at 4℃.Control antibody (green line) was human IgG1 (1ug/1*10⁶cells) used under the same conditions. Acquisition of >10,000 events was performed.

Description

Neural cell adhesion molecule 1, commonly known as CD56 or NCAM1, serves as a critical mediator of cell-cell interactions in the nervous system and plays essential roles in neural development, synaptic plasticity, and neuronal migration. Beyond its neurobiological functions, NCAM1 has gained significant attention as a defining marker for natural killer cells and certain neuroendocrine tumors, making it a valuable target across neuroscience, immunology, and oncology research.

This recombinant monoclonal antibody against human NCAM1 offers the reproducibility and consistency that demanding experimental workflows require. Produced using recombinant technology with a defined sequence, this antibody eliminates the lot-to-lot variability that can compromise longitudinal studies or multi-site collaborations. The human IgG1 isotype format, combined with affinity chromatography purification, ensures high purity and reliable performance across validated applications.

Functional validation demonstrates exceptional binding characteristics, with ELISA testing revealing an EC50 in the sub-nanogram range of 0.89 to 1.02 ng/mL when binding to immobilized human NCAM1 protein. For flow cytometry applications, this antibody has been validated using SH-SY5Y cells, a human neuroblastoma line that endogenously expresses NCAM1, showing clear positive signal separation from isotype control at dilutions between 1:50 and 1:500. These validation data provide researchers with confidence when designing experiments and optimizing protocols.

Whether investigating neural development mechanisms, characterizing NK cell populations, or exploring NCAM1 expression patterns in neuronal cell models, this antibody delivers the specificity and sensitivity needed for meaningful results. The versatility across both ELISA and flow cytometry platforms provides flexibility for researchers approaching NCAM1 biology from multiple experimental angles.

Customer Reviews and Q&A

■ Customer Reviews

Submit a Review here

Target Background

Function(From Uniprot)

This protein is a cell adhesion molecule involved in neuron-neuron adhesion, neurite fasciculation, outgrowth of neurites, etc.; (Microbial infection) Acts as a receptor for rabies virus.; (Microbial infection) Acts as a receptor for Zika virus.

Gene References into Functions

CD56 is a potentially good immunohistochemical marker for differentiating papillary thyroid carcinoma from other benign follicular lesions of the thyroid PMID:30173227
TROP-2, SLP-2 and CD56 were effective diagnostic markers for PTC, especially when they were combined to use. PMID:29951933
evaluation of the diagnostic value of emerin and CD56 in papillary thyroid carcinoma, using immunohistochemistry PMID:30188764
Plasma levels of NCAM-1 were found to be lower in coronary artery disease patients compared to controls. PMID:29506702
CD200(+) and/or CD56(+) positive expression in B-ALL patients at diagnosis is a poor prognostic biomarker. PMID:29161980
CD56 immunohistochemistry can be useful in differentiating follicular variant papillary thyroid carcinoma from follicular adenoma. PMID:29799356
NCAM1 protein expression levels were found to be regulated by miRNA-572 in an oligodendroglial cell line. PMID:28332001
a role for CD56 in developmental synapse structure, natural killer (NK) cell motility and NK cell development. PMID:27435370
The expression of CD56 was analyzed in 74 samples of primary MM cells collected from patients before they received bortezomib plus dexamethasone therapy. Expression of NCAM was lower among patients who responded poorly. In vitro expression of NCAM induced by transfection of MM cells enhanced their sensitivity to Btz treatment by causing accumulation of polyubiquitinated proteins. PMID:29738534
Results show that the conjugate selectively depleted the CSC population of the tumors and effectively inhibited tumor growth without causing toxicity. We propose that the NCAM-targeted conjugate could be an effective therapeutic for Wilms tumor. PMID:28729402
CD200 and/or CD56 positive expression in B-ALL at diagnosis suggest a poor prognosis and may be associated with biological aggressiveness. PMID:29144828
This study concludes that the cytotoxic action of CD56+ fraction of cytokine-induced killer cells against a K562 cell line is mainly due to the natural killer cells. PMID:27136441
NCAM1 was up-regulated in the malignant Middle Cerebral Artery Infarction. PMID:28828208
This supports the conclusion that a lower proportion of CD56(bright) natural killer regulatory cells results in the high rate of chronic graft-versus-host disease seen in filgrastim-stimulated apheresis peripheral blood. PMID:28935847
inhibiting NCAM1 would be cardioprotective, counteract the pathological action of TGFbeta1 and reduce heart failure severity. PMID:28870505
Mutation of a putative MAP kinase (Erk2) consensus site regulates neural cell adhesion molecule (NCAM) endocytosis and NCAM-dependent neurite outgrowth. PMID:28193531
The combined use of CK19 and CD56 is helpful in discriminating papillary thyroid carcinoma and its variants from other mimicking thyroid lesions. PMID:28214214
NCAM-expression in adult dilated cardiomyopathy hearts is associated with cardiomyocyte hypertrophy. PMID:28343767
This study identified NCAM1 gene sets related to self-reported depression scores in healthy participants PMID:28334615
Basal cell carcinoma (BCC) typically shows patchy CD56 expression and diffuse CK5/6 positivity. These 2 markers can be used to distinguish between BCC and Merkel cell carcinoma in challenging cases. PMID:28403527
Study represents the first to evaluate the prognostic impact of CD56 expression in a real-life setting and address these findings to a large and heterogeneous subset of AML. PMID:26914377
T-cell differentiation and CD56+ levels are different in polypoidal choroidal vasculopathy and neovascular age-related macular degeneration. PMID:29165313
findings that the CD56 and CD117 expression levels are lower in advanced stages than earlier stages and that LDH level and CD117 expression have an inverse relationship in patients with newly diagnosed multiple myeloma (MM) suggest that CD56 and CD117 expressions may be prognostic markers for MM. PMID:28270374
soluble NCAM might be thought as a specific marker of peripheral nerve demyelination and as a sensitive marker of peripheral nerve injuries PMID:28336415
Neural cell adhesion molecule (NCAM, CD56) is a transmembrane glycoprotein. PMID:27528376
Suggest that INSM1 is valuable for identification of the high-grade thoracic neuroendocrine carcinomas that are sometimes negative for synaptophysin, chromogranin, and CD56. PMID:28719469
CD56(bright) NK IL-7Ralpha expression negatively associates with HCV level, and IL-7-induced NK function is impaired during HCV and HIV infections PMID:28400540
These findings provide evidence for newly-discovered roles for PREP in mechanisms regulating cellular plasticity through NCAM and PSA-NCAM. PMID:27566163
NCAM- and FGF-2-mediated FGFR1 signaling in the tumor microenvironment regulates the survival and migration of esophageal squamous carcinoma cells. PMID:27317650
Study provides detailed description of the PSA-NCAM distribution throughout the human brain and quantitatively compares control, Alzheimer's and Parkinson's disease. Results demonstrate that PSA-NCAM-mediated structural plasticity may not be limited to neurogenic niches and is conserved in the aged brain, provide evidence that PSA-NCAM is reduced in the entorhinal cortex. PMID:27282086
The purpose of this study is to reveal whether neural cell adhesion molecule (NCAM) mediates the protective effects of GDNF. PMID:27003822
Suppressor function of CD56bright NK cells is impaired in multiple sclerosis. PMID:27157273
data provided molecular details about the interaction between HuPrP and the NCAM fibronectin domain, and revealed a new role of PrP(C) N terminus as a dynamic and functional element responsible for protein-protein interaction. PMID:27535221
The polybasic region of the polysialyltransferase ST8Sia-IV binds directly to NCAM. PMID:28233978
analysis of structural and genetic features of the CD56 glycoprotein, and summary of its roles in the normal versus diseased metanephric blastema [review] PMID:27935326
novel RUNX1 isoforms contribute in controlling CD56 expression in acute myeloid leukemia cells. PMID:26706848
NCAM1 SNPs were associated with lifetime cannabis use, but the association did not reach genome-wide significance. [Meta-Analysis] PMID:27023175
analysis of natural killer cell markers in renal transplantation that have roles in acute rejection reveals that CD56 and CD57 are increased in the interstitial compartment in donor-specific antibody (DSA)-negative biopsies from patients with acute antibody-mediated rejection without C4d, and CD16 is increased in the glomerular compartment in DSA-positive biopsies PMID:26615051
Data show that negative selection for CD133 is required for defining NCAM1(+) nephron stem cells in normal and malignant nephrogenesis. PMID:27020553
Report increased CD56 expression by immature biliary epithelial cells in biliary atresia. PMID:26937142
NCAM1 deletion is associated with neuroblastoma and ganglioneuroma. PMID:26463893
this study shows that CD56 expression defines a poor prognosis subset in the cytogenetically intermediate prognosis pediatric AML. PMID:26147745
The expression of coding and non-coding genes with SAFB1 cross-link sites was altered by SAFB1 knockdown. The isoform-specific expression of neural cell adhesion molecule (NCAM1) and ASTN2 was influenced by SAFB1. PMID:26694817
the expression of CD56 in adenomyosis is positively associated with the severity of dysmenorrhea. PMID:26344352
A FOXP3(+)CD3(+)CD56(+)-expressed T-cell population with immunosuppressive function and reduced patient survival has been identified in cancer tissues of human hepatocellular carcinoma. PMID:26437631
NK cell maturation to CD56(dim) subset associated with high levels of NCRs overrides the inhibitory effect of NKG2A and recovers impaired NK cell cytolytic potential after allogeneic hematopoietic stem cell transplantation. PMID:26856773
The neural cell adhesion molecule (NCAM) is a glycoprotein implicated in cell-cell adhesion, neurite outgrowth and synaptic plasticity. PMID:26460482
L1-CAM and N-CAM: From Adhesion Proteins to Pharmacological Targets PMID:26478212
CD56 marker is a useful alternative that is comparable to SSTR2A for the diagnosis of phosphaturic mesenchymal tumors. PMID:26339384
Case Report: chronic lymphocytic leukemia with aberrant CD56 and CD57 expression. PMID:26013700

Hide All

Subcellular Location

[Isoform 1]: Cell membrane; Single-pass type I membrane protein.; [Isoform 2]: Cell membrane; Single-pass type I membrane protein.; [Isoform 3]: Cell membrane; Lipid-anchor, GPI-anchor.; [Isoform 4]: Cell membrane; Lipid-anchor, GPI-anchor.; [Isoform 5]: Secreted.; [Isoform 6]: Secreted.

Database Links

HGNC: 7656

UNIGENE: Hs.503878

KEGG: hsa:4684

STRING: 9606.ENSP00000318472

OMIM: 116930

Promotions